Motor
Restless Leg Syndrome
search
Restless Leg Syndrome
, Restless Legs Syndrome, Ekboms Syndrome
See Also
Periodic Limb Movement
Akathisia
Leg Pain
Movement Disorder
Pediatric Restless Leg Syndrome
Epidemiology
Fourth leading cause of
Insomnia
Family History
of restless legs in 50-60%
Incidence
in adults: 6-10% (only 2 to 3% seek treatment)
Incidence
in adults over age 65 years: 10-28%
More common in women
Onset before age 18 in one third of patients
Risk Factors
Family History
of Restless Leg Syndrome (accounts for 50% of RLS patients)
Iron Deficiency Anemia
(especially if
Serum Ferritin
<50 ng/ml)
Chronic Renal Failure
(
Chronic Kidney Disease
)
Antidepressant
use (
Akathisia
)
Pregnancy
Neuropathy
Pathophysiology
Possible etiologies
Dopamine
deficiency in
Brainstem
or spinal cord
Endogenous
Opiate
deficiency
Small fiber
Peripheral Neuropathy
Causes
Idiopathic in most cases
Iron Deficiency Anemia
Renal
Dialysis
Pregnancy (as high as 19%)
Hypothyroidism
Diabetes Mellitus
Electrolyte
disturbance
Decreased
Serum Magnesium
Decreased
Serum Folate
Leg varicosities
May be relieved with sclerotherapy
Drug-induced causes
See
Akathisia
Selective Serotonin Reuptake Inhibitor
s (common)
Antihistamine
s (e.g.
Benadryl
)
Antipsychotic
s
Antiemetic
s
Phenergan
Metoclopramide
Prochlorperazine
Lithium
Tricyclic Antidepressant
s (e.g.
Elavil
)
Treat with
Propranolol
40 mg PO tid
Substances
Caffeine
Tobacco
use
Symptoms
Timing
Symptoms worsen in the afternoon, evening and bedtime
Contrast with
Periodic Limb Movement
which occurs during sleep
Overall urge to move legs due to uncomfortable leg
Sensation
s (
Akathisia
)
Creeping or crawling restlessness
Wormy or boring
Sensation
Tingling, pins and needles, or prickly
Sensation
Pulling or drawing
Sensation
Severity
Symptoms can cause very significant morbidity (to point of
Suicidal Ideation
)
Palliative
Movement (e.g. walking) temporarily relieves
Sensation
until sitting or lying back down again
Provocative
Prolonged period of inactivity (e.g. car travel)
Prolonged sitting (e.g. classes or meetings)
Lying down or sleeping
Signs
Periodic flexions
Occur every 20-40 seconds during non-
REM Sleep
Labs
Serum Ferritin
(<50 ng/ml associated with Restless Leg Syndrome)
Serum Glucose
Serum Creatinine
Consider other lab testing to consider
Thyroid Stimulating Hormone
Serum Magnesium
Serum Folate
Differential Diagnosis
See
Akathisia
Periodic Limb Movement
Night Cramp
s (
Leg Cramp
s)
Peripheral Vascular Disease
Anxiety Disorder
Drug induced
Akathisia
Peripheral Neuropathy
Tic Disorder
Diagnosis
Essential Features (4 criteria)
Intense urge to move legs (typically asssociated with uncomfortable creeping or aching leg
Sensation
s) AND
Symptoms begin or worsen with rest or inactivity AND
Symptoms are at least in part relieved with walking or
Stretching
AND
Worse or limited to evening and overnight
Management
Gene
ral measures
Discontinue provocative habits
Discontinue
Caffeine
usage
Tobacco Cessation
Alcohol
cessation
Encourage relaxing bedtime routine
Avoid vigorous
Exercise
2 hours before bedtime
Avoid sexual activity 2 hours before bedtime
Adjust schedule to allow awakening later
Correct
Iron Deficiency Anemia
Screen with
Serum Ferritin
in most if not all patients with Restless Leg Syndrome
Consider
Iron Supplementation
for
Serum Ferritin
<75 mcg/L
Local massage (leg massage)
Moderate intensity
Exercise
(e.g. brisk walking) may also decrease symptoms longterm
Cold compress application
Consider adaptive changes at work or school
Work at high desk with stool
Sit in aisle seat on trips or meetings
Consider sleep clinic referral for refractory symptoms
Management
GABA
Agents (preferred first line)
First-line option for persistent restless legs
Delayed onset of relief while starting and titrating medication
Better tolerated longterm than the
Dopamine
rgic agents (listed above)
Similar efficacy to the
Dopamine
rgic agents (50% symptom reduction with NNT 5)
Gabapentin
(
Neurontin
)
Start: 300 mg orally at bedtime
Increase: every 3-4 nights until symptoms controlled or at a maximum of 1800 mg
Effective in RCT at 1800 mg/day (600 mg tid)
Garcia-Borreguero (2002) Neurology 59:1573-9 [PubMed]
Pregabalin
(
Lyrica
)
Start 300 mg orally at bedtime
Management
Non-Ergotamine
Dopamine Agonist
s (preferred second line)
Preferred for frequent or nightly restless legs symptoms
Quick onset of improved symptoms
Risk of sedation,
Nausea
,
Hallucination
s and
Compulsive Gambling
and other behaviors
Augmentation (worsening symptoms) occurs in 6-7% of patient per year
Switch to
GABA
Agent (
Gabapentin
or
Pregabalin
) - see below
Pramipexole
(
Mirapex
)
Initial dose: 0.125 mg one tablet orally at bedtime
Subsequent: Increase dose every third night until symptoms controlled or at a maximum of 4 tablets at bedtime
See
Mirapex
for dosing strategy
Ropinirole
(
Requip
)
Initial dose: 0.25 mg orally at bedtime
Subsequent: Increase dose every third night until symptoms controlled or at a maximum of 4 tablets at bedtime
See
Requip
for dosing strategy
Rotigotine
(
Neupro
) Transdermal
Dopamine Agonist
transdermal patch
Indicated for moderate to severe symptoms refractory to
Pramipexole
or
Ropinirole
Dosing
One patch applied daily to a new site
Do not repeat the same site for 14 days
Start at 1 mg/24 hours
May increase weekly to a maximum of 3 mg/24 hours
Management
Other agents
Analgesic
s at bedtime
Acetaminophen
(
Tylenol
)
NSAID
S (e.g.
Ibuprofen
)
Nighttime
Opioid Analgesic
s (e.g.
Oxycodone
5-10 mg at bedtime) may also be effective
Dopamine Agonist
s
Consider for occsional symptoms
Carbidopa and
Levodopa
Sinemet
12.5/50 mg PO qhs prn
Sinemet
CR 25/100 mg PO qhs prn
Ergotamine
Dopamine Agonist
s
Pergolide (Permax) 0.05 to 1 mg
First dose at dinner
Second dose one hour before bed
Cabergoline
(
Dostinex
)
Initial dose: 0.5 mg PO at bedtime
Benzodiazepine
s
Not recommended
Alpha Adrenergic Agonist
s
Clonidine
0.1 mg PO qhs
Course
Symptoms progress with age
Resources
Restless Legs Syndrome Foundation
http://www.rls.org
References
(2017) Presc Lett 24(4):20-1
(2000) Am Fam Physician 62:108-14 [PubMed]
Bayard (2008) Am Fam Physician 78(2): 235-43 [PubMed]
Clark (2001) J Am Board Fam Pract 14:368-74 [PubMed]
Henning (1999) Sleep 22:970-99 [PubMed]
Holder (2022) Am Fam Physician 105(4): 397-405 [PubMed]
Paulson (2000) Geriatrics 55:35-48 [PubMed]
Ramar (2013) Am Fam Physician 88(4): 231-8 [PubMed]
Type your search phrase here